Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

SYNTHEMA Synthetic generation of hematological data over federated computing frameworks

Coordinator
Universidad Politecnica De Madrid, Spain
Runs
1 December 2022 to 30 November 2026
Status
Running
EU funding
€6.5m
Total cost
€6.5m
Partners
16 organisations in 10 countries
Type
Research and Innovation Action
Grant agreement
101095530

What the project is doing

In the project's own words, from its summary on CORDIS.

Haematological diseases (HDs) are a large group of disorders resulting from quantitative or qualitative abnormalities of blood cells, lymphoid organs and coagulation factors. Despite most of them (~74%) are rare, the overall number of HD affected patients worldwide is important, placing a considerable economic burden on healthcare systems and societies. Despite the existence of several collaborative research groups at national and EU level, current clinical approaches are often ineffective, particularly for rarest conditions, due to the relatively low number of patients per disease and the high number of unconnected clinical entities.

SYNTHEMA aims to establish a cross-border data hub where to develop and validate innovative AI-based techniques for clinical data anonymisation and synthetic data generation (SDG), to tackle the scarcity and fragmentation of data and widen the basis for GDPR-compliant research in RHDs. The project will focus on two representative RHD use cases: sickle-cell disease (SCD) and acute myeloid leukaemia (AML). SYNTHEMA will develop a federated learning (FL) infrastructure, equipped with secure multiparty computation (SMPC) and differential privacy (DF) protocols, connecting clinical centres bringing standardised, interoperable multimodal datasets and computing centres from academia and SME.

This framework will be utilised to train the developed algorithms and perform SMPC-based global model aggregation in a privacy-preserving fashion. The resulting data will be validated for their clinical value, statistical utility and residual privacy risks. The project will develop legal and ethical frameworks to guarantee privacy by-design in the collection and processing of health-related personal data and attain an ethics-wise algorithm co-creation.

Project outcomes, including pipelines, standards and data, will be made openly available to stakeholders in the healthcare, academia and industry field, and contribute to existing rare disease registries

Topics

Who is involved

OrganisationCityCountryRole
Universidad Politecnica De MadridMadridSpainCoordinator
Sba Research Gemeinnutzige GmbHWienAustriaParticipant
The European Institute for Innovation Through Health DataGentbruggeBelgiumParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Australo Interinnov Marketing Lab SLMadridSpainParticipant
Fundacio Hospital Universitari Vall D'hebron - Institut De RecercaBarcelonaSpainParticipant
Fundacion Centro De Tecnologias De Interaccion Visual Y Comunicaciones VicomtechDonostia San SebastianSpainParticipant
Assistance Publique Hopitaux De ParisParisFranceParticipant
Alma Mater Studiorum - Universita Di BolognaBolognaItalyParticipant
Datawizard SRLRomaItalyParticipant
Humanitas Mirasole SpARozzano (Mi)ItalyParticipant
Universita Degli Studi Di PadovaPadovaItalyParticipant
Netcompany S.a.LuxembourgLuxembourgParticipant
Universitair Medisch Centrum UtrechtUtrechtNetherlandsParticipant
Glsmed Learning Health SALisboaPortugalParticipant
University of SouthamptonSouthamptonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI